middle.news
Chimeric Therapeutics Shows Tumour Shrinkage at Highest CAR-T Dose
9:04am on Thursday 16th of July, 2026 AEST
•
Healthcare
Read Story
Chimeric Therapeutics Shows Tumour Shrinkage at Highest CAR-T Dose
9:04am on Thursday 16th of July, 2026 AEST
Key Points
Four patients treated at 450 million CAR-T cells dose
Tumour shrinkage between 17% and 40% in individual lesions
Stable disease maintained up to six months in two patients
No new safety concerns beyond initial dose-limiting toxicity
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Chimeric Therapeutics (ASX:CHM)
OPEN ARTICLE